Navigating the nexus of MRD and novel agents in ALL

The landscape of acute lymphoblastic leukemia (ALL) has evolved significantly over the last few years. Identification of specific recurrent genetic alterations and of minimal residual disease (MRD) guides prognostic classification and management. Novel agents (eg, blinatumomab) have demonstrated enc...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Hematology Am Soc Hematol Educ Program
Main Authors: Advani, Anjali S., Copelan, Edward A.
Format: Artigo
Sprog:Inglês
Udgivet: American Society of Hematology 2019
Fag:
Acute Lymphoblastic Leukemia: Aiming High to Keep MRD Low, or Even Better, Negative
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6913439/
https://ncbi.nlm.nih.gov/pubmed/31808877
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/hematology.2019000008
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker